RT Journal Article
SR Electronic
T1 635 A phase 1, first in human (FIH) study of autologous macrophages engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants (pts) with HER2 overexpressing solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A726
OP A726
DO 10.1136/jitc-2023-SITC2023.0635
VO 11
IS Suppl 1
A1 Reiss, Kim
A1 Mortimer, Joanne
A1 Pohlmann, Paula R
A1 Johnson, Melissa
A1 Maziarz, Richard T
A1 Specht, Jennifer
A1 Claire Dees, E
A1 Yuan, Yuan
A1 Ueno, Naoto
A1 Angelos, Mathew
A1 Gill, Saar
A1 Condamine, Thomas
A1 Cushing, Daniel
A1 Barton, Debora
A1 Klichinsky, Michael
A1 Swaby, Ramona F
A1 Abdou, Yara
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A726.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.